UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549
Form 6-K
REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2022
Commission File Number: 1-32575
Shell plc(Exact name of registrant as specified in its charter)
England and Wales(Jurisdiction of incorporation or organization)
Shell CentreLondon, SE1 7NAUnited Kingdom(Address of principal executive office)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 18-K
For Foreign Governments and Political Subdivisions Thereof
ANNUAL REPORT
OF THE
FEDERATIVE REPUBLIC OF BRAZIL
(Name of Registrant)
Date of end of last fiscal year: December 31, 2021
SECURITIES REGISTERED*
(As of the close of the fiscal year)
Title of Issue
Amounts as to
which registration
is effective
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 7, 2022
8i Acquisition 2 Corp.
(Exact Name of Registrant as Specified in its Charter)
British Virgin Islands 001-40462 n/a
(State or other jurisdiction
of ... (continue reading...)
More SEC Filings
View Older Stories-
Form SC TO-I QIWI Filed by: Dalliance Services Co
-
Form 6-K CHINA LIFE INSURANCE CO For: Jul 07
-
Form 8-K 8i Acquisition 2 Corp. For: Jul 07
-
Form 8-K BIMI International Medic For: Jul 05
-
Form 10-Q EDUCATIONAL DEVELOPMENT For: May 31
-
Form 6-K Legend Biotech Corp For: Jul 07
-
Form 424B3 VerifyMe, Inc.
-
Form 8-K Bridgeline Digital, Inc. For: Jul 05
-
Form 8-K Iconic Brands, Inc. For: Jun 30
-
Form 8-K WORLD WRESTLING ENTERTAI For: Jul 06
-
Form ABS-EE CARMAX AUTO FUNDING LLC For: Jun 30
-
Form DEFA14A AeroClean Technologies,
-
Form 6-K PORTAGE BIOTECH INC. For: Jul 06
-
Form 6-K Osisko Development Corp. For: Jul 07
-
Form D/A VVP Focus Fund, LLC
-
Form 8-K iMine Corp For: Jul 01
-
Form DEFA14A MERIDIAN BIOSCIENCE INC
-
Form DEFA14A MERIDIAN BIOSCIENCE INC
-
Form SC 13D/A Forte Biosciences, Inc. Filed by: BML Investment Partners, L.P.
-
Form 8-K AMERICOLD REALTY TRUST For: Jul 06
-
Form FWP HSBC USA INC /MD/ Filed by: HSBC USA INC /MD/
-
Form D METROPOLITAN TOWER LIFE
-
Form 6-K WPP plc For: Jul 07
-
Form 4 VERIZON COMMUNICATIONS For: Jul 05 Filed by: Silliman Craig L.
-
Form 485BXT FRANKLIN STRATEGIC SERIE
-
Form 8-K TENNECO INC For: Jul 07
-
Form 8-K Guardant Health, Inc. For: Jun 30
-
Form 6-K H World Group Ltd For: Jul 07
-
Form DEFA14A SERVICESOURCE INTERNATIO
-
Form 8-K ORAMED PHARMACEUTICALS For: Jul 07
-
Form 8-K SERVICESOURCE INTERNATIO For: Jul 07
-
Form 8-K NORTHERN TECHNOLOGIES For: Jul 07
-
Form 8-K China Green Agriculture, For: Jul 05
-
Form 4 TScan Therapeutics, Inc. For: Jul 05 Filed by: Barton Debora
-
Form 13F-HR FULTON BANK, N.A. For: Jun 30
-
Form 3 TScan Therapeutics, Inc. For: Jul 05 Filed by: Barton Debora
-
Form DEF 14A CNS Pharmaceuticals, For: Jul 27
-
Form 6-K SciSparc Ltd. For: Jul 07
-
Form DEF 14A Spectrum Brands Holdings For: Aug 09
-
Form 4 PAR PACIFIC HOLDINGS, For: Jul 05 Filed by: SILBERMAN ROBERT S
-
Form DEFA14A MERIDIAN BIOSCIENCE INC
-
Form 4 PAR PACIFIC HOLDINGS, For: Jul 05 Filed by: DODS WALTER A JR
-
Form 8-K Enact Holdings, Inc. For: Jun 30
-
Form 8-K RVL Pharmaceuticals plc For: Jul 07
-
Form 4 PAR PACIFIC HOLDINGS, For: Jul 05 Filed by: Clossey Timothy
-
Form 6-K DR REDDYS LABORATORIES For: Jul 06
-
Form 6-K Lightspeed Commerce Inc. For: Jul 07
-
Form 8-K MERIDIAN BIOSCIENCE INC For: Jul 07
-
Form 8-K INTERCEPT PHARMACEUTICAL For: Jul 07
-
Form 6-K Iris Energy Ltd For: Jul 07